| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
CAMBRIDGE, Mass.—At the recent meeting of the American Association for Cancer Research, AVEO Pharmaceuticals announced the development of the first platform for the generation of fully human breast tumors in mice. According to company scientists, the Human-in-Mouse (HIM) system is a significant improvement over current xenograph models of human breast cancer and should facilitate more realistic efficacy studies in preclinical drug testing.
 
Dr. Murray Robinson, AVEO's vice president of oncology, presented the HIM model system as part of a symposium titled: Modeling Abnormal Proliferation in Model Organisms. "As we further develop our portfolio of novel oncology products, such as AV-412, the HIM system and AVEO's proprietary Human Response Prediction platform will help us design clinical trials with a higher likelihood of success," said Tuan Ha-Ngoc, president and CEO of AVEO.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue